Preclinical Imaging and Molecular Imaging for Advanced Biomedical Research

At ZRO Imaging, our state-of-the-art imaging center and imaging laboratory integrate multiple imaging technologiesto deliver robust, actionable data. Our capabilities span microCT, microPET, microSPECT, and microMRI, enabling both structural and functional assessment of disease models. This comprehensive approach supports research from early discovery through translational stages, whether in collaboration with a cancer center or leading biomedical institutions.

Micro-CT Imaging

Our microCT technology supports preclinical research in Alzheimer’s disease, oncology, and related biomedical fields. We use high-resolution, 3D imaging to assess brain structure, track regional atrophy, and visualize cerebrovascular changes in animal models. MicroCT delivers detailed morphometric data, making it ideal for both longitudinal and endpoint studies. It’s precise, non-invasive, and efficient.

MicroPET/SPECT/CT

We combine microPET and SPECT with CT to reveal molecular pathways in live animals. This emission tomographymodality uses radioactive tracers to highlight tumor metabolism, receptors, and drug delivery in real time. The CT component adds anatomical context, giving you both function and form in one scan. It’s well-suited for studying pharmacokinetics, drug targeting, disease mechanisms, and therapeutic efficacy.

MicroMR

MicroMRI delivers high-resolution, non-invasive imaging of soft tissues with exceptional detail. Using molecularcontrast agents, we can highlight inflammation, vascular changes, and microstructural features. Advanced diffusion and functional MR techniques provide deeper insight. MicroMRI complements PET, SPECT, CT, and optical systems for a complete, multi-modal perspective.

Track drug behavior in real time with our in vivo drug labeling studies. Using radioactive tags, we monitor biodistribution, clearance, metabolism, and target engagement in living systems. Sensitive detection via microPETprovides clear, early insights into compound performance—helping you make faster, data-driven go/no-go decisions in drug development.

We deliver clear data, fast turnaround, and expert support to keep your projects on track. Our team works across all major imaging modalities—including microCT, MRI, PET/SPECT—and selects the right approach for your study goals. We combine quantitative image analysis with expert interpretation to give you actionable insights. As your strategic partner, we handle everything from study design to image processing. Whether you're investigating molecular targets, disease mechanisms, or therapeutic effects, our quantitative imaging and deep expertise translate into actionable insights—helping you move forward with confidence.

At ZRO, we take on each project with focus and follow-through. Whether you need microPET to quantify tracer uptake or a custom imaging protocol for complex models, we tailor the approach to your goals—and we deliver. We bring together specialized instrumentation, experienced scientists, and a hands-on mindset. We're thorough, responsive, and committed to doing things properly, even under pressure. From study design to data analysis, we work with intent—so you get results you can trust, on timelines that keep your program moving.